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to adrenocortical cells under high steroidogenic pressure 
conditions, like stress. More specifi cally, probucol-induced 
lowering of both HDL-cholesterol and LDL-cholesterol 
levels in mice is associated with a >55% decrease in the 
glucocorticoid response to endotoxemia ( 1 ). Studies in 
LCAT and APOA1 knockout mice, respectively, have indi-
cated that a specifi c decrease in plasma HDL-cholesterol 
levels is associated with a 25–50% decrease in the maximal 
adrenal glucocorticoid output ( 2, 3 ). Moreover, disrup-
tion of (adrenal-specifi c) HDL receptor function in mice 
is associated with a 40–50% decrease in the adrenocortical 
steroidogenic capacity ( 4, 5 ). 
 Male carriers of functional mutations in the HDL bio-
genesis genes, ABCA1 and LCAT, display a decrease in the 
24 h urinary excretion rate of adrenal-derived steroids ( 6 ). 
However, basal and stimulated plasma cortisol levels are 
similar in HDL-defi cient male ABCA1 and LCAT mutation 
carriers and their normolipidemic controls ( 6 ). Further-
more, both the urinary glucocorticoid excretion rate and 
cortisol response to corticotropin are unaltered in females 
with genetically low HDL ( 7 ). The presence of relatively 
low HDL-cholesterol levels is, thus, in striking contrast to 
what is observed in mice: not consistently associated with 
glucocorticoid insuffi ciency in humans. 
 In vitro studies have suggested that both HDL and 
APOB-containing lipoproteins, i.e., VLDL and LDL, can 
theoretically supply cholesterol to adrenocortical cells ( 8–
11 ). Importantly, human subjects exhibit a markedly dif-
ferent lipoprotein profi le as compared with mice. The 
majority of cholesterol in humans is carried by LDL, while 
the murine lipoprotein profi le is characterized by rela-
tively low to absent levels of cholesterol associated with 
VLDL/LDL in the context of normal HDL-cholesterol lev-
els. The relative importance of HDL-associated cholesterol 
as steroidogenic substrate can, thus, hypothetically be dif-
ferent between these two specifi c species due to the fact 
that human plasma, as compared with murine plasma, 
contains additional potential cholesterol sources, i.e., LDL 
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 Glucocorticoids are produced from the common ste-
roidogenic precursor, cholesterol. It is generally accepted 
that under basal conditions suffi cient amounts of choles-
terol are acquired from endogenous synthesis by the adre-
nals. However, it has become evident from studies in 
genetically modifi ed mice that lipoproteins, in particular 
HDLs, are important for delivering cholesterol substrate 
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stained with hematoxylin (Sigma) and Oil red O (Sigma) for 
lipid visualization. 
 Real-time quantitative PCR 
 Gene expression analysis was performed essentially as de-
scribed ( 16 ). Equal amounts of RNA were reverse transcribed 
and real-time quantitative PCR analysis was subsequently exe-
cuted on the cDNA using an ABI Prism 7500 apparatus (Applied 
Biosystems, Foster City, CA) according to the manufacturer’s in-
structions. Acidic ribosomal phosphoprotein P0 (36B4), GAPDH, 
succinate dehydrogenase complex subunit A fl avoprotein (SDHA), 
peptidylprolyl isomerase A (PPIA),   -2-microglobulin (B2M), 
transferrin receptor (TFRC), and   -actin (ACTB) were used as 
housekeeping genes for normalization. 
 Data analysis 
 Statistical analysis was performed using GraphPad InStat soft-
ware (San Diego, CA, http://www.graphpad.com). Normality of 
the experimental groups was confi rmed using the method of Kol-
mogorov and Smirnov. The signifi cance of differences was calcu-
lated using a two-tailed unpaired  t -test or two-way ANOVA where 
appropriate. Probability values less than 0.05 were considered 
signifi cant. 
 RESULTS 
 Regular chow diet-fed LDLR knockout mice exhibit a 
highly similar lipoprotein profi le to that observed in nor-
molipidemic humans ( 13 ). To investigate whether the 
contribution of HDL to adrenal glucocorticoid output is 
different in mice with a human-like lipoprotein profi le, we 
determined the impact of genetic HDL defi ciency in mice 
on a LDLR knockout genetic background. Hereto, HDL-
defi cient APOA1 knockout mice were crossbred with LDLR 
SKO mice to generate the respective APOA1/LDLR DKO 
mice. 
 As can be appreciated from  Fig. 1A , plasma free and to-
tal cholesterol levels did not signifi cantly differ between 
regular chow diet-fed male DKO and SKO mice. How-
ever, lipoprotein distribution analysis on pooled plasma 
( Fig. 1B ) revealed that DKO mice exhibited a highly simi-
lar reduction in plasma HDL-cholesterol levels (  65%), 
as previously noted in APOA1 knockout mice on a wild-
type background ( 3 ). DKO mice showed a parallel 89% 
increase in levels of cholesterol associated with VLDL 
particles, as compared with their respective APOA1-con-
taining SKO controls ( Fig. 1B ). As a result, the plasma 
nonHDL-cholesterol over HDL-cholesterol ratio was, thus, 
markedly higher in DKO mice as compared with SKO mice 
( Fig. 1C ). 
 Previous studies by the group of Dr. Mary Sorci-Thomas 
have suggested that, after a short-term (4 h) fasting pe-
riod, the adrenals of DKO mice are severely depleted of 
cholesterol esters, despite the fact that DKO mice still carry 
  30% of the normal amount of HDL-associated choles-
terol in APOE-enriched HDL particles ( 17 ). Quantifi cation 
of the adrenal lipid stores revealed that both free choles-
terol (  21%;  P = 0.002) and cholesterol ester (  51%;  P = 
0.005) levels were also markedly lower in the adrenals of 
our DKO mice, as compared their SKO controls, after an 
and VLDL. To provide experimental proof for this hy-
pothesis in the current study, we determined the impact of 
HDL defi ciency on the adrenal glucocorticoid output in 
genetically modifi ed mice that contain a human-like lipo-
protein profi le. 
 MATERIALS AND METHODS 
 Animals 
 APOA1 knockout mice lacking a functional APOA1 protein 
( 12 ) were provided on a hyperlipidemic LDL receptor (LDLR) 
knockout background ( 13 ) by Dr. J. A. Kuivenhoven from the 
Amsterdam Medical Center (Amsterdam, The Netherlands). 
These APOA1/LDLR double knockout (DKO) mice were subse-
quently inbred to maintain an in-house colony. 
 Male APOA1/LDLR DKO (N = 14) and control LDLR single 
knockout (SKO) mice (N = 14) were maintained on a regular 
chow diet. Throughout the experiment, both types of mice were 
housed in the same climate-controlled stable with a 12 h/12 h 
dark-light cycle and handled identically. At 4 months of age, ad 
libitum-fed age-matched mice (N = 6 per genotype) were bled at 
9:00 AM from the tail to obtain a basal plasma corticosterone 
measurement. Subsequently, these six mice per genotype were 
injected intraperitoneally with a sublethal dose (50   g/kg) of li-
popolysaccharide from  Salmonella minnesota R595 and euthanized 
2 h later to measure the maximum endotoxemia-related plasma 
corticosterone response ( 1, 14 ). The remaining mice (N = 8 per 
genotype) were subjected to overnight fasting by food depriva-
tion from 5:00 PM onwards. At 9:00 AM the next morning, mice 
were bled via the tail for fasting plasma corticosterone and blood 
glucose measurements. After anesthesia by subcutaneous injec-
tion with a mix of 70 mg/kg bodyweight xylazine, 1.8 mg/kg 
bodyweight atropine, and 350 mg/kg bodyweight ketamine, 
mice were bled via retro-orbital bleeding, euthanized, and sub-
jected to whole body perfusion with ice-cold PBS. Adrenals were 
collected free of surrounding fat, weighed, and stored at   20°C 
or fi xed overnight in 3.7% neutral-buffered formalin solution 
(Formalfi xx; Shandon Scientifi c Ltd, UK). All animal work was 
approved by the Leiden University Animal Ethics Committee and 
performed in compliance with the Dutch government guidelines 
and Directive 2010/63/EU of the European Parliament. 
 Blood and plasma analyses 
 Corticosterone levels in tail blood plasma were determined us-
ing the corticosterone  3 H RIA kit from ICN Biomedicals accord-
ing to the protocol from the supplier. Plasma concentrations of 
free cholesterol and cholesterol esters were determined using 
enzymatic colorimetric assays. The cholesterol distribution over 
the different lipoproteins in plasma was analyzed by fraction-
ation of 30   l pooled plasma of each mouse genotype using a 
Superose 6 column (3.2 × 30 mm, Smart-system; Pharmacia). Total 
cholesterol content of the effl uent was determined using enzymatic 
colorimetric assays. Blood glucose levels were routinely measured 
using a calibrated Accu-Check glucometer (Roche Diagnostics, 
Almere, The Netherlands) 
 Adrenal lipid composition and histology 
 Lipids from adrenals were extracted using the method of Bligh 
and Dyer ( 15 ). After dissolving the lipids in 1% Triton X-100, the 
contents of free cholesterol and cholesterol esters were determined 
using enzymatic colorimetric assays and expressed as micrograms 
per milligram of protein. Seven micrometer cryosections were 
prepared on a Leica CM3050-S cryostat. Cryosections were routinely 
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neutral lipids in their adrenal cortex. In contrast, an equally 
low extent of lipid accumulation was microscopically de-
tected within cortical cells of DKO adrenals ( Fig. 2B ), as 
previously noted in glucocorticoid insuffi cient LCAT knock-
out mice and probucol-treated C57BL/6 mice ( 1, 2 ). 
overnight fast ( Fig. 2A ), suggesting that the adrenal lipid 
depletion effect associated with APOA1 defi ciency is 
independent of the metabolic/stress state. Oil red O stain-
ing of adrenal cryostat sections further verifi ed adrenal 
lipid depletion. Adrenals from SKO mice had abundant 
 Fig. 1. Plasma free and total cholesterol levels (A), the cholesterol distribution over the different lipoprotein fractions (B), and the 
plasma nonHDL- to HDL-cholesterol ratio (C) in age-matched male APOA1/LDLR DKO and LDLR SKO mice. 
 Fig. 2. A: Adrenal free cholesterol and cholesterol ester levels in APOA1/LDLR DKO and LDLR SKO mice. B: Representative images of 
Oil red O-stained adrenal sections showing neutral lipid depletion in the cortex of DKO mice. C: Adrenal relative gene expression levels as 
measured by quantitative PCR. ** P < 0.01, *** P < 0.001 versus SKO. HMGCR, HMG-CoA reductase . 
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signifi cant 6.6-fold increase ( P < 0.001 vs. basal) in circulat-
ing corticosterone levels in SKO mice, as anticipated. 
Strikingly, corticosterone levels were virtually identical in 
both groups of fasted mice (256 ± 21 ng/ml for DKO vs. 
269 ± 15 ng/ml for SKO;  P > 0.05). HDL defi ciency thus 
does not seem to be associated with glucocorticoid insuf-
fi ciency in mice with a human-like lipoprotein. In agree-
ment with a normal metabolic glucocorticoid action in 
HDL-defi cient mice, DKO mice did not display hypoglyce-
mia, as compared with SKO mice under fasting conditions 
( Fig. 3B ). The induction of endotoxemia is associated with 
a concomitant rise in the plasma level of glucocorticoids 
( 21, 22 ). In further support of a similar maximal steroido-
genic capacity of the adrenals in the two types of mice, 
equally high levels of corticosterone (  250 ng/ml;  Fig. 
3A ) were detected in the plasma of SKO and DKO mice 
after induction of endotoxemia through injection of a sub-
lethal dose of lipopolysaccharide. 
 DISCUSSION 
 In the current study, we tested the hypothesis that a dif-
ference in lipoprotein profi le between mice and humans 
can explain the relative importance of HDL-cholesterol as 
substrate for adrenal steroidogenesis. 
 A 70% reduction in plasma HDL-cholesterol levels in 
APOA1 SKO mice is associated with a severe depletion of 
adrenal cholesterol ester stores and a concomitant impair-
ment of the adrenal glucocorticoid response to stress ( 3 ). 
The APOE-rich HDL particles remaining in these mice 
( 23 ) are apparently not able to compensate for the lack of 
 An effi cient feedback system exists that modulates the 
expression of genes involved in cholesterol synthesis and 
uptake in response to changes in intracellular cholesterol 
levels [reviewed by Sato and Takano ( 18 )]. Quantitative 
real-time PCR was employed to uncover possible compen-
satory gene regulation. No change was noted, as compared 
with SKO adrenals, in the relative mRNA expression level 
of the HDL receptor, SR-BI, in DKO adrenals ( Fig. 2C ). In 
addition, genetic APOA1 defi ciency was not associated 
with a difference in relative mRNA expression levels of 
hormone-sensitive lipase (HSL), ACAT-1, and steroido-
genic acute regulatory protein (STAR) that are respec-
tively involved in the de- and re-esterifi cation of cholesterol 
and intracellular mobilization of cholesterol to the ste-
roidogenic pathway ( Fig. 2C ). However, we did observe a 
marked increase (425%;  P < 0.001;  Fig. 2C ) in the mRNA 
expression of the enzyme, HMG-CoA reductase, in DKO 
adrenals. It thus appears that, in a human-like lipoprotein 
context, HDL defi ciency in mice is associated with deple-
tion of adrenal cholesterol stores despite a compensatory 
increase in intra-adrenal cholesterol synthesis. 
 Levels of the primary glucocorticoid, corticosterone, 
were measured in plasma under basal and stressed condi-
tions to verify whether the depletion of adrenal choles-
terol esters also executed a negative impact on the overall 
steroid output. In line with the general notion that lipo-
protein-derived cholesterol is not required for the synthe-
sis of glucocorticoids under low steroidogenic conditions, 
plasma corticosterone levels were similar in nonstressed 
ad libitum-fed SKO and DKO mice ( Fig. 3A ). Food depri-
vation is a powerful inducer of an adrenal glucocorticoid 
response in mice ( 19, 20 ). Overnight fasting resulted in a 
 Fig. 3. A: Plasma corticosterone levels in APOA1/LDLR DKO and LDLR SKO mice measured in the basal 
state, in response to overnight food deprivation (fasting), and after injection with lipopolysaccharide (endo-
toxemia). B: Plasma glucose levels as measured in the fasted state.  # P < 0.001 versus respective basal values. 
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by these circulating lipid/protein complexes. Consider-
able evidence is, however, present that SR-BI is also able to 
facilitate the uptake of cholesterol from APOB-containing 
lipoproteins. Initial in vitro studies by Swarnakar et al. 
( 29 ) and Stangl, Hyatt, and Hobbs ( 30 ) showed that mu-
rine SR-BI is able to mediate the selective uptake of choles-
terol esters from human LDL. Subsequent cell culture 
studies by Webb et al. ( 31 ) verifi ed a similar interaction of 
SR-BI with autologous mouse LDL. In support of a parallel 
role for SR-BI in APOB-containing lipoprotein cholesterol 
delivery in vivo, the removal from the blood circulation 
and tissue uptake of   -migrating VLDL particles, LDL, 
and chylomicron-remnants has been shown to be signifi -
cantly lower in mice lacking functional SR-BI expression 
( 32–34 ). As a result, SR-BI knockout mice not only display 
increased plasma levels of HDL-cholesterol, but also ex-
hibit an increase in the amount of cholesterol carried by 
APOB-containing lipoproteins ( 35 ), while plasma levels of 
APOB-containing lipoproteins are markedly lower in mice 
upon transgenic or adenoviral overexpression of SR-BI 
( 36, 37 ). Adrenal glucocorticoid output is diminished in 
human subjects carrying a functional mutation in the SR-
BI gene ( 38 ). Several heterozygote SR-BI P297S carriers 
actually show signs of adrenal dysfunction in spite of mark-
edly increased plasma HDL-cholesterol levels ( 38 ). Given 
that, in the human situation, disruption of SR-BI function 
appears to be associated with a more extreme effect on the 
adrenal steroidogenic capacity than genetic lowering of 
HDL-cholesterol levels, it can be suggested that, in our 
current human-like lipoprotein setting, the impaired acquisi-
tion of cholesterol from APOA1-containing HDL particles 
can be fully compensated by enhanced cholesterol synthe-
sis combined with SR-BI-mediated delivery of cholesterol 
from APOB-containing lipoproteins to the adrenals. 
 Novel intervention strategies to reduce cardiovascular 
disease risk, such as proprotein convertase subtilisin/kexin 
type 9 (PCSK9) antibody treatment and statin/ezetimibe 
combination therapies, are aimed at reaching extremely 
low plasma LDL-cholesterol levels. No remarkable adre-
nal-associated events have been reported in meta-analyses 
of anti-PCSK9 antibody ( 39 ) and statin/ezetimibe trials 
( 40 ). This may, at fi rst sight, argue against our current 
working hypothesis that APOB-containing lipoproteins 
serve as primary cholesterol donors for steroidogenesis. 
However, one should take into account that:  1 ) adrenal 
dysfunction may only become evident under stress condi-
tions; and  2 ) in-depth adrenal function testing is not com-
mon within these cardiovascular-oriented clinical trials. 
As such, inclusion of the adrenocorticotropic hormone 
(ACTH) stimulation test, the standard method to assess 
the maximal adrenal cortisol response, in trial protocols 
may aid in validating our hypothesis in the human setting. 
In light of our challenging concept, it is of interest to note 
that several case studies by Illingworth and colleagues ( 41–
43 ) have indicated that genetic LDL defi ciency (abetalipo-
proteinemia) in humans is associated with subclinical 
adrenal insuffi ciency, as evident from an impaired ACTH-
induced cortisol response and a lower urinary (free) corti-
sol excretion rate. 
cholesterol supplied by APOA1-containing particles for 
steroidogenesis. Although it cannot be excluded that the 
APOE-rich HDL is a poor substrate for adrenal cholesterol 
delivery, we anticipate that the adrenal cholesterol insuf-
fi ciency observed in APOA1 SKO mice is primarily the re-
sult of an overall too low amount of HDL particles being 
present in the circulation. 
 Genetic variations in the APOA1 gene have also been 
associated with HDL defi ciency in humans ( 24–26 ). How-
ever, due to the limited number of subjects with genetic 
APOA1 defi ciency, the specifi c contribution of APOA1-
containing HDL particles to adrenal steroidogenesis remains 
to be determined in the human setting. In the current 
study, we observed that APOA1 defi ciency in mice with a 
human-like lipoprotein, i.e., on a LDLR knockout (hyper-
lipidemic) background, is associated with a similar 65% 
reduction in plasma HDL-cholesterol levels and adrenal 
cholesterol depletion, as observed in APOA1 knockout mice 
on a wild-type (normolipidemic) background. In contrast, 
APOA1/LDLR DKO mice do not suffer from glucocorti-
coid insuffi ciency, as their maximal glucocorticoid output 
is similar to that of HDL-containing single LDLR knockout 
controls. It thus appears that the presence of a human-like 
lipoprotein profi le alleviates the glucocorticoid insuffi -
ciency associated with APOA1 defi ciency in mice. 
 Studies by Plump et al. ( 3 ) have suggested that adrenals 
from APOA1 knockout mice are still able to respond to 
stress, although to a minor extent as compared with those 
of wild-type mice, due to compensatory upregulation of 
pathways that are normally of minor importance, such as 
cholesterol uptake by the LDLR and de novo cholesterol 
synthesis. A 5-fold increase in the gene expression of 
HMG-CoA reductase in the adrenals of DKO mice was de-
tected under fasting stress conditions, which suggests that 
de novo cholesterol synthesis is stimulated to compensate 
for the loss of HDL-cholesterol. In contrast to our DKO 
mice, HDL-defi cient LCAT knockout mice do display a di-
minished adrenal glucocorticoid function despite a 
marked 6-fold increase in adrenal HMG-CoA reductase 
expression ( 2 ). From these combined fi ndings, it can be 
concluded that such a 5- to -6-fold increase in adrenal 
HMG-CoA reductase expression is, by itself, not suffi cient 
to overcome adrenal glucocorticoid insuffi ciency. All mice 
used in the current study did not express a functional 
LDLR, which excludes a compensatory role for LDLR-me-
diated cholesterol acquisition by adrenals in DKO mice. In 
vitro studies by Kraemer et al. ( 27 ) have suggested that the 
LDLR is of negligible importance for acute steroidogene-
sis by adrenocortical cells. Furthermore, the levels of corti-
costerone measured in the fasting state in male LDLR 
knockout mice in the current experiment are almost 
identical to those found in male wild-type mice in our pre-
vious studies ( 28 ). We therefore consider it highly unlikely 
that the impact of APOA1/HDL defi ciency on glucocorti-
coid output in vivo is dependent on the adrenal LDLR 
genotype. 
 In our experimental setup, APOB-containing lipopro-
teins could not be cleared by the LDLR, which is normally 
suggested to be the primary route of cholesterol delivery 
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